Status:
UNKNOWN
Auricular Acupressure : Improves Oxaliplatin-induced Peripheral Neuropathy
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Oxaliplatin-induced Peripheral Neuropathy
Chemotherapy
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Oxaliplatin-induced peripheral neuropathy (OIPN) is a common adverse effect that becomes worse as the drug dose accumulation impacts cancer patients' daily activities and quality of life.The result of...
Detailed Description
Objectives: Oxaliplatin-induced peripheral neuropathy (OIPN) is a common adverse effect that becomes worse as the drug dose accumulation impacts cancer patients' daily activities and quality of life....
Eligibility Criteria
Inclusion
- Colorectal cancer patients who are above the age of 20 years
- Have experiencing Oxaliplatin induced peripheral neuropathy
- Must be able to communicate
- Willing to fill out the inform consent
Exclusion
- Symptoms of peripheral neuropathy caused by diabetes mellitus
- Symptoms of peripheral neuropathy caused by genetic disease
- Symptoms of peripheral neuropathy caused by spinal cord injury
- Symptoms of peripheral neuropathy caused by alcoholism
- With wounds on ears
- Allergy to latex (the tapes for the auricular acupressure include latex)
Key Trial Info
Start Date :
August 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 20 2021
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT04751513
Start Date
August 21 2020
End Date
August 20 2021
Last Update
February 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital
Taipei, Taiwan, 10507